专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010120845A2 BACKLIGHT AND DISPLAY SYSTEM INCORPORATING SAME 审中-公开
标题翻译：背光和显示系统
公开(公告)号：WO2010120845A2
公开(公告)日：2010-10-21
申请号：PCT/US2010030984
申请日：2010-04-14
申请人： 3M INNOVATIVE PROPERTIES CO , COGGIO WILLIAM D , WHEATLEY JOHN A , LIU TAO , OSTLIE BRIAN W , HAO ENCAI , KOLB WILLIAM BLAKE , WANG QINGBING , FREE MICHAEL BENTON , STEINER MICHAEL L , TAPIO SCOTT M
发明人： COGGIO WILLIAM D , WHEATLEY JOHN A , LIU TAO , OSTLIE BRIAN W , HAO ENCAI , KOLB WILLIAM BLAKE , WANG QINGBING , FREE MICHAEL BENTON , STEINER MICHAEL L , TAPIO SCOTT M
IPC分类号： G02B6/00
CPC分类号： G02B6/0051 , G02B5/02 , G02B6/0056 , G02B2207/107
摘要： Lightguide is disclosed. The lightguide includes a light guiding layer for propagating light by total internal reflection, and an optical film that is disposed on the light guiding layer. The optical film includes a plurality of voids, an optical haze that is not less than about 30%, and a porosity that is not less than about 20%. Substantial portions of each two neighboring major surfaces in the lightguide are in physical contact with each other.
摘要翻译：光导被披露。光导包括用于通过全内反射传播光的导光层和设置在导光层上的光学膜。光学膜包括多个空隙，不小于约30％的光学雾度和不小于约20％的孔隙率。导光板中每两个相邻的主要表面的实质部分彼此物理接触。

2. 发明申请

WO2009151842A3 ILLUMINATION DEVICE WITH PROGRESSIVE INJECTION 审中-公开
标题翻译：具有渐进式注射的照明装置
公开(公告)号：WO2009151842A3
公开(公告)日：2010-03-04
申请号：PCT/US2009043405
申请日：2009-05-11
申请人： 3M INNOVATIVE PROPERTIES CO , WHEATLEY JOHN A , BIERNATH ROLF W , MEIS MICHAEL A , FREIER DAVID G , LIU TAO , NEVITT TIMOTHY J
发明人： WHEATLEY JOHN A , BIERNATH ROLF W , MEIS MICHAEL A , FREIER DAVID G , LIU TAO , NEVITT TIMOTHY J
IPC分类号： G02F1/13357 , F21V8/00 , G02F1/1335
CPC分类号： G02F1/133605 , G02F1/133603 , G02F1/133611
摘要： Illumination devices having a partially transmissive front reflector, a back reflector, and a cavity between them are disclosed. At least one light injector including a baffle and a light source is disposed in the cavity. The light injector is capable of injecting partially collimated light into the cavity. The output area of the illumination device can be increased by disposing light injectors progressively within the cavity, without sacrificing uniformity of the light emitted through the output area.
摘要翻译：公开了具有部分透射的前反射器，后反射器和它们之间的空腔的照明装置。包括挡板和光源的至少一个光注射器设置在空腔中。光注射器能够将部分准直的光注入空腔。可以通过将光注入器逐渐地设置在空腔内来增加照明装置的输出面积，而不会牺牲通过输出区域发射的光的均匀性。

3. 发明申请

WO2006009907A2 ISOXAZOLIDINE COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS 审中-公开
标题翻译：用于治疗细菌感染的ISOXAZOLIDINE化合物
公开(公告)号：WO2006009907A2
公开(公告)日：2006-01-26
申请号：PCT/US2005021589
申请日：2005-06-17
申请人： INFINITY PHARMACEUTICALS INC , CHRISTENSEN BURTON G , FOLEY MICHAEL A , GEORGES EVANGELINOS ASIMINA T , LIU TAO , PORTER JAMES R , RIPKA AMY S , ZHANG LINPING
发明人： CHRISTENSEN BURTON G , FOLEY MICHAEL A , GEORGES EVANGELINOS ASIMINA T , LIU TAO , PORTER JAMES R , RIPKA AMY S , ZHANG LINPING
IPC分类号： C07D413/00
CPC分类号： C07D261/02 , C07D413/12
摘要： The present invention relates to antibiotic compounds and intermediates useful in their preparation. Many of the antibiotic compounds contain a substituted isoxazolidine ring. The invention also relates to pharmaceutical compositions containing a compound of the invention. The invention further provides processes for the preparation of compounds of the invention, and methods for their use as therapeutic agents.
摘要翻译：本发明涉及可用于其制备的抗生素化合物和中间体。许多抗生素化合物含有取代的异恶唑烷环。本发明还涉及含有本发明化合物的药物组合物。本发明还提供了制备本发明化合物的方法及其用作治疗剂的方法。

4. 发明申请

WO2012126440A3 METHOD, DEVICE AND SYSTEM FOR OBTAINING DATA TYPE DEFINITION 审中-公开
标题翻译：方法，用于获取数据类型定义的设备和系统
公开(公告)号：WO2012126440A3
公开(公告)日：2013-04-18
申请号：PCT/CN2012076290
申请日：2012-05-30
申请人： HUAWEI TECH CO LTD , LIU TAO
发明人： LIU TAO
IPC分类号： H04L29/08
CPC分类号： H04L67/16 , G06F17/30943
摘要： Provided are a method, device and system for obtaining a data type definition. The data type definitions are managed by a data type definition management server in a centralized way, and the data type definition is sent to a terminal device according to the request thereof, so that the data type definition can be invoked repeatedly by different terminal devices, improving the reusability of the data type definition.
摘要翻译：提供了一种用于获得数据类型定义的方法，设备和系统。数据类型定义由数据类型定义管理服务器以集中的方式管理，并且数据类型定义根据其请求被发送到终端设备，使得可以由不同的终端设备重复地调用数据类型定义，提高数据类型定义的可重用性。

5. 发明申请

WO2013012915A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF 审中-公开
标题翻译：杂环化合物及其用途
公开(公告)号：WO2013012915A1
公开(公告)日：2013-01-24
申请号：PCT/US2012047186
申请日：2012-07-18
申请人： INFINITY PHARMACEUTICALS INC , INTELLIKINE LLC , CASTRO ALFREDO C , EVANS CATHERINE A , JANARDANANNAIR SOMARAJANNAIR , LESCARBEAU ANDRE , LIU TAO , SNYDER DANIEL A , TREMBLAY MARTIN R , REN PINGDA , LIU YI , LI LIANSHENG , CHAN KATRINA
发明人： CASTRO ALFREDO C , EVANS CATHERINE A , JANARDANANNAIR SOMARAJANNAIR , LESCARBEAU ANDRE , LIU TAO , SNYDER DANIEL A , TREMBLAY MARTIN R , REN PINGDA , LIU YI , LI LIANSHENG , CHAN KATRINA
IPC分类号： C07D471/04 , A61K31/4725 , A61P37/00 , C07D487/04
CPC分类号： C07D471/04 , C07D473/34 , C07D487/04 , C07D495/04 , C07D513/04
摘要： Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
摘要翻译：本文描述了调节激酶活性（包括PI3激酶活性）的化合物和药物组合物，以及化合物，药物组合物和治疗与激酶活性（包括PI3激酶活性）相关的疾病和病症的方法。

6. 发明申请

WO2012167398A1 PREPARATION METHODS OF CORE-SHELL NANOPARTICLES AND SOLUTION THEREOF 审中-公开
标题翻译：核壳纳米颗粒的制备方法及其解决方案
公开(公告)号：WO2012167398A1
公开(公告)日：2012-12-13
申请号：PCT/CN2011000950
申请日：2011-06-07
申请人： BAYER TECHNOLOGY AND ENGINEERING SHANGHAI CO LTD , BAYER TECHNOLOGY SERVICES GMBH , FU MIN , LIU TAO , DIETER HEINZ , LU HUA-CHANG , LESLAW MLECZKO
发明人： FU MIN , LIU TAO , DIETER HEINZ , LU HUA-CHANG , LESLAW MLECZKO
IPC分类号： C09K11/54 , C09K11/08 , C09K11/84
CPC分类号： C30B7/14 , B01J13/02 , B82Y40/00 , C09K11/025 , C09K11/565 , C09K11/621 , C30B29/48 , C30B29/60 , H01L31/055 , Y02E10/52
摘要： Provided are preparation methods of core-shell nanoparticles and solution thereof. The preparation method of a core-shell nanoparticle solution comprises the following steps: adjusting the temperature of a semiconductive nanoparticle solution to a presetting shell layer encapsulating temperature; adding the shell layer precursor solution to the semiconductive nanoparticle solution, and reacting at the presetting shell layer encapsulating temperature, wherein the shell layer precursor solution is formed by mixing zinc salt, alkyl thiol and nonpolar organic solvent; after the reaction carries on for a period of presetting reacting time, the core-shell nanoparticle solution is obtained. The core-shell nanoparticles have the merits of high fluorescence quantum yield, nontoxic, low production cost, and simple process.
摘要翻译：提供核 - 壳纳米粒子及其溶液的制备方法。核 - 壳纳米颗粒溶液的制备方法包括以下步骤：将半导体纳米颗粒溶液的温度调节至预设的壳层包封温度; 将壳层前体溶液加入到半导体纳米颗粒溶液中，并在预置壳层封装温度下反应，其中壳层前体溶液通过混合锌盐，烷基硫醇和非极性有机溶剂形成; 反应进行预设反应时间后，得到核 - 壳纳米粒子溶液。核壳纳米粒子具有荧光量子产率高，无毒，生产成本低，工艺简单等优点。

7. 发明申请

WO2008063300A8 BORONIC ACIDS AND ESTERS AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE 审中-公开
标题翻译：作为脂肪酸酰胺水解酶的抑制剂的有机酸和酯类
公开(公告)号：WO2008063300A8
公开(公告)日：2009-06-11
申请号：PCT/US2007021626
申请日：2007-10-10
申请人： INFINITY PHARMACEUTICALS INC , ADAMS JULIAN , BEHNKE MARK L , CASTRO ALFREDO C , EVANS CATHERINE A , GRENIER LOUIS , GROGAN MICHAEL J , LIU TAO , SNYDER DANIEL A , TIBBITTS THOMAS T
发明人： ADAMS JULIAN , BEHNKE MARK L , CASTRO ALFREDO C , EVANS CATHERINE A , GRENIER LOUIS , GROGAN MICHAEL J , LIU TAO , SNYDER DANIEL A , TIBBITTS THOMAS T
IPC分类号： A61K31/69 , A61P29/00
CPC分类号： C07F5/025 , A61K31/69 , C07F5/05
摘要： The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.
摘要翻译：本发明提供由式（I），（II）或（III）包含的化合物及其药物组合物。本发明还提供了通过给予治疗有效量的所提供的式（I），（II）或（III）化合物或其药物组合物来治疗FAAH介导的疾病，病症或病症的方法，需要。此外，本发明提供了通过向有需要的患者施用治疗有效量的式（I），（II）或（III）化合物或其药物组合物来抑制患者的FAAH的方法。

8. 发明申请

WO2008054473A9 MODIFIED CARBON NANOTUBES AND METHODS OF FORMING CARBON NANOTUBES 审中-公开
标题翻译：改性碳纳米管和形成碳纳米管的方法
公开(公告)号：WO2008054473A9
公开(公告)日：2008-06-26
申请号：PCT/US2007006138
申请日：2007-03-09
申请人： BATTELLE MEMORIAL INSTITUTE , HEINTZ AMY M , ELHARD JOEL D , RISSER STEVEN M , LIU TAO , MOORE BRYON P , VIJAYENDRAN BHIMA R
发明人： HEINTZ AMY M , ELHARD JOEL D , RISSER STEVEN M , LIU TAO , MOORE BRYON P , VIJAYENDRAN BHIMA R
IPC分类号： C01B31/02 , C03C17/22 , C03C17/34 , C09D5/24 , H01B1/04
CPC分类号： C09D5/24 , B82Y30/00 , B82Y40/00 , C01B32/168 , C01B32/174 , C01B2202/28 , C03C17/007 , C03C17/22 , C03C17/3441 , C03C17/42 , C03C2217/42 , C08K3/04 , C09D7/61 , H01B1/04 , Y10S977/751 , Y10S977/752 , Y10S977/932 , Y10T428/25 , Y10T428/30
摘要： In this invention, electrolytic, photochemical, chemical, and encapsulation processes can be used to achieve substantially completely stable doped carbon nanotubes. Preferred CNT structures and morphologies for achieving maximum doping effects are also described. Dopant formulations and methods for achieving doping of a broad distribution of tube types are also described.
摘要翻译：在本发明中，可以使用电解，光化学，化学和封装方法来实现基本上完全稳定的掺杂碳纳米管。还描述了用于实现最大掺杂效应的优选CNT结构和形态。还描述了用于实现管型广泛分布的掺杂的掺杂剂配方和方法。

9. 发明申请

WO2006074587A8 A DEVICE AND METHOD FOR FAST SIGNALLING BASED ON HYBRID AUTOMATIC REPEAT REQUEST PROCESS ID 审中-公开
标题翻译：基于混合自动重复请求过程ID的快速信令的设备和方法
公开(公告)号：WO2006074587A8
公开(公告)日：2008-05-02
申请号：PCT/CN2005001674
申请日：2005-10-12
申请人： ZTE CORP , PENG FOCAI , LV KAIYING , LIU TAO
发明人： PENG FOCAI , LV KAIYING , LIU TAO
IPC分类号： H04J13/00
CPC分类号： H04L1/1867 , H04L1/1812
摘要： The present invention relates to a device and method for fast signalling based on HARQ Process ID, including a process information handling unit and a fast signalling and HARQ Process ID coding handling unit at the Node B side, and a process information handling unit and a fast signalling and HARQ Process ID coding handling unit at the UE side. The method includes steps of: the Node B controls the number of process transmitted to each UE; the Node B codes the fast signalling to be transmitted and the HARQ Process ID transmitted to each UE; the UE decodes and gets the original HARQ Process ID data and original fast signalling data according to a predetermined coding process method. According to this method, Node B can make use of the HARQ Process ID on the HS-SCCH to transmit additional fast signalling data.
摘要翻译：本发明涉及基于HARQ进程ID的快速信令装置和方法，包括过程信息处理单元和节点B侧的快速信令和HARQ过程ID编码处理单元，以及处理信息处理单元和快速信令处理单元信令和HARQ进程ID编码处理单元。该方法包括以下步骤：节点B控制发往每个UE的进程数; 节点B对要发送的快速信令和发送到每个UE的HARQ进程ID进行编码; UE根据预定的编码处理方法解码并获取原始HARQ进程ID数据和原始快速信令数据。根据该方法，节点B可以利用HS-SCCH上的HARQ进程ID来发送附加的快速信令数据。

10. 发明申请

WO2008024337A3 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS 审中-公开
标题翻译：用于阻止BCL蛋白与结合的伙伴相互作用的化合物和方法
公开(公告)号：WO2008024337A3
公开(公告)日：2008-04-17
申请号：PCT/US2007018471
申请日：2007-08-21
申请人： INFINITY DISCOVERY INC , CASTRO ALFREDO C , DEPEW KRISTOPHER M , GROGAN MICHAEL J , HOLSON EDWARD B , HOPKINS BRIAN T , JOHANNES CHARLES W , KEANEY GREGG F , KONEY NII O , LIU TAO , MANN DAVID A , NEVALAINEN MARTA , PELUSO STEPHANE , PEREZ LAWRENCE BLAS , SNYDER DANIEL A , TIBBITTS THOMAS T
发明人： CASTRO ALFREDO C , DEPEW KRISTOPHER M , GROGAN MICHAEL J , HOLSON EDWARD B , HOPKINS BRIAN T , JOHANNES CHARLES W , KEANEY GREGG F , KONEY NII O , LIU TAO , MANN DAVID A , NEVALAINEN MARTA , PELUSO STEPHANE , PEREZ LAWRENCE BLAS , SNYDER DANIEL A , TIBBITTS THOMAS T
IPC分类号： C07D261/02 , A61K31/422 , A61P35/00 , C07D413/10 , C07D413/12 , C07D417/12
CPC分类号： C07D261/02 , A61K31/42 , A61K31/422 , A61K31/427 , A61K31/4439 , A61K31/454 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D413/10 , C07D413/12 , C07D417/12
摘要： The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit BcI function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
摘要翻译：本发明涉及含有异恶唑烷的化合物，其与bcl蛋白结合并抑制Bcl功能。这些化合物可用于治疗和调节与过度增殖相关的疾病，例如癌症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式